Peculiarities of Abdominal Pain Syndrome in Patients with Functional and Inflammatory Bowel Diseases and Methods of Its Correction

Main Article Content

A.E. Dorofeiev
O.A. Rassokhina
Ye.А. Кirian
I.А. Derkach
А.Yu. Butova


Objective of this study was to evaluate peculiarities of abdominal pain syndrome in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) and to assess efficacy of Enterospasmil in complex therapy of these patients. 120 patients with IBS and 35 patients with IBD were examined. Age of patients varied from 18 to 65 years. Abdominal pain syndrome was detected in all patients with IBS and IBD. In examined patients we have detected predominantly variable, without irradiation, often of blunt, aching nature, lasting more than 3 hours, with moderate intensity. Enterospasmil is an effective drug for abdominal pain relief in patients with IBS and IBD and can be used in complex therapy of these patients.

Article Details

How to Cite
Dorofeiev, A., Rassokhina, O., Кirian Y., Derkach, I., & Butova А. (2014). Peculiarities of Abdominal Pain Syndrome in Patients with Functional and Inflammatory Bowel Diseases and Methods of Its Correction. GASTROENTEROLOGY, (4.54), 101–105.
Original Researches


Ардатская М.Д. Синдром избыточного бактериального роста: Уч. пос. / М.Д. Ардатская. — М.: Форте принт, 2011. — 56 с.

Клеточные и системные механизмы действия пробиотиков / А.И. Калмыкова, В.Г. Селятицкая, Н.А. Пальчикова [и др.]. — Новосибирск, 2007. — 280 с.

Ткаченко Е.И. Дисбиоз кишечника. Руководство по диагностике и лечению / Е.И. Ткаченко, А.Н. Суворова. — СПб.: Спецлит, 2007. — 238 с.

Bixquert Jimûnez Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? / Bixquert Jimûnez // Rev. Esp. Enfem. Dig. — 2009. — Vol. 101, № 8. — P. 553-564.

Collins S.M. The interplay between the intestinal microbiota and the brain / S.M. Collins, M. Surette, P. Bercik // Nature Reviews Microbiology. — 2012. — Vol. 10. — P. 735-742.

Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells / S.T. Dorsam, E. Vomhof-DeKrey, R.J. Hermann [et al.] // Molecular Immunology. — 2010. — Vol. 47, № 6. — P. 1181-1194.

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome / Drouault, S. Holowacs, S. Bieuvelet [et al.] // Gastroenterol. Clin. Biol. — 2008. — Vol. 32, № 2. — P. 147-152.

WGO Practice Guideline — Irritable Bowel Syndrome: a global perspective / Q. Eamon [et al.]. — World Gastroenterology Organisation, 2009.

Adoptive transfer of macrophage from mice with depression-like behavior enhances susceptibility to colitis / J.E. Ghia, A.J. Park, P. Blennerhassett [et al.] // Inflammatory Bowel Di-seases. — Vol. 17, № 7. — Р. 1474-1489.

Correlation of gut hormones with irritable bowel syndrome / H. Zhang Y. Yan, R. Shi [et al.] // Digestion. — 2008. — Vol. 78, № 2–3. — P. 72-76.